Ozempic’s next move, Southwest’s seating change, and Big Tech’s troubles: Business news roundup
Since Russia’s invasion of Ukraine in 2022, a Faraday curtain descended across European airspace from the Baltic Sea in the north to the Black Sea in the south. Over 46,000 planes have reported GPS issues while flying over the Baltic since last August. While aviation officials don’t believe Russia is purposely targeting foreign civilian aircraft, the interference still poses a safety risk. It’s been a decade since Malaysia Airlines Flight 17 was shot down over eastern Ukraine by Russian separatists.
Southwest Airlines is considering changing its notorious seating policy, according to chief executive officer Bob Jordan. “We’re looking at new initiatives like the way we seat and the way we board our aircrafts,” Jordan told CNBC. Jordan said the company has been “studying” its seating and cabin arrangements but no changes have been finalized just yet.
Southwest primarily follows an open-seating style, meaning passengers don’t have assigned seats ahead of getting on their flights. Instead, customers are assigned boarding groups; once onboard, they pick any open seat.
Millions of Americans could now be eligible for Medicare to cover their prescriptions of the popular weight loss drug Wegovy, according to a new analysis by KFF. The highly coveted medication belongs to the same class of drug as diabetes medication Ozempic, which is also known for its weight loss side effects.
UnitedHealth Group, the parent company of the largest health insurer in the U.S., confirmed this week that it paid a ransom in relation to a cyberattack on its subsidiary Change Healthcare earlier this year.
Comments are closed.